Samedan Ltd Pharmaceutical Publishers


Advanced search

Publications European Pharmaceutical Contractor European Biopharmaceutical Review International Clinical Trials Pharmaceutical Manufacturing and Packing Sourcer Innovations in Pharmaceutical Technology Subscribe Online White Papers Samedan app Pharmaceutical Directory Industry Events Calendar News and Press Releases Employment Opportunities Advertising with us Contact Us

home > ict

PUBLICATIONS

International Clinical Trials

International Clinical Trials (ICT) is a specialist journal designed to provide global coverage of key topics pertinent to the clinical trials sector.

Published quarterly, and edited by Dr Graham Hughes, the journal offers a platform of communication and information-sharing for executive and strategic decision-makers, seeking out new trends and marketing opportunities, as well as putting a spotlight on the latest innovations coming to market. ICT is specifically designed to be of interest to those actively seeking to source services for improved efficiency in what is an increasingly competitive market.

For further information please contact:
Advertising David Hirsh Nick Matthews	Editorial Rupert Gilbey

View the digital version of ICT

	Subscribe
	Current Issue
	Archives
	Media Info
	Our Clients

Featured in this issue

Regional Trials
Outsourcing: Southeast Asia

Into the East

Building on its Phase 2 and 3 capabilities, Southeast Asia is improving its early-stage trial set-up, infrastructure and regulation – making this fast-expanding market a winning ticket for multinational pharma. Nick Beckett and David Pountney at CMS set the scene.

TRIAL MANAGEMENT
Study Feasibility

Get Started

The cornerstone of a successful clinical trial, feasibility assessment enables CROs to address risks and delays in start-up and patient enrolment before a study begins. A Savateyev, M Belotserkovsky, D Palumbo and K Moscicka at PSI explain.

CLINICAL THERAPEUTICS
Alternative Medicine

Yes, we CAM

From mind-body medicine to vitamin supplements, complementary and alternative treatments are gaining in popularity – prompting the need for greater awareness of how they interact with products and patients in trials. Marcin and Martyna Stefanowicz at Trial-Med explain.

Edited by
Dr Graham Hughes
Consultant in
Pharmaceutical
Development

Published quarterly in
February, May,
August and November

Industry Events

Clinical Trial Supply New England 2014

11-12 March 2014, Boston, United States

This event will focus on key issues experienced by smaller and medium sized companies. We know that sometimes smaller and medium sized firms are overlooked when it comes to Clinical Trial Supply events. Many solutions offered just aren't suitable. So how can we help?
More info >>

All events >>

News and Press Releases

Hygiene Properties of Steel Belts are Second to None

The big dangers in designing any conveyor system used in the food, beverage, packaging, and pharmaceutical industries are the breeding of microorganisms within the machinery and spreading of pathogenic microorganisms by the machinery. Pre-requisites therefore are materials free from crevices, which may trap dirt, manufactured from non- corrosive materials and which are easy to clean.
More info >>

All releases >>

Air Transport Publications

White Papers

Sourcing Commercial Drugs for Clinical Trials: US vs. EU Understanding the Differences

Myoderm

Sourcing commercial drugs for clinical trials is a dynamic process. There are many factors to consider: single source or regional sourcing, strategy, price, supply availability, lead times, and documentation are just a few. In the past, there were fewer clinical trials that required commercial drug sourcing, so demand was not as high. Today, the demand for commercial drugs in clinical trials has greatly increased and, as a result, inventory is tighter, orders are monitored more closely by manufacturers, and lead times have increased. This report highlights the key differences in sourcing from the US and EU.
More info >>

All white papers >>